<HashMap><database>biostudies-literature</database><scores/><additional><submitter>de Carvalho BT</submitter><funding>Vlaams Instituut voor Biotechnologie</funding><funding>Vlaams Instituut voor Biotechnologie (VIB)</funding><pagination>e0032524</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11218656</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>90(6)</volume><pubmed_abstract>&lt;i>Saccharomyces boulardii&lt;/i> has been a subject of growing interest due to its potential as a probiotic microorganism with applications in gastrointestinal health, but the molecular cause for its probiotic potency has remained elusive. The recent discovery that &lt;i>S. boulardii&lt;/i> contains unique mutations causing high acetic acid accumulation and inhibition of bacterial growth provides a possible clue. The natural &lt;i>S. boulardii&lt;/i> isolates Sb.P and Sb.A are homozygous for the recessive mutation &lt;i>whi2&lt;/i>&lt;sup>S270*&lt;/sup> and accumulate unusually high amounts of acetic acid, which strongly inhibit bacterial growth. However, the homozygous &lt;i>whi2&lt;/i>&lt;sup>S270*&lt;/sup> mutation also leads to acetic acid sensitivity and acid sensitivity in general. In the present study, we have construct</pubmed_abstract><journal>Applied and environmental microbiology</journal><pubmed_title>Enhancing probiotic impact: engineering &lt;i>Saccharomyces boulardii&lt;/i> for optimal acetic acid production and gastric passage tolerance.</pubmed_title><pmcid>PMC11218656</pmcid><funding_grant_id>GC02-C06</funding_grant_id><pubmed_authors>Thevelein JM</pubmed_authors><pubmed_authors>Subotic A</pubmed_authors><pubmed_authors>Vermeire S</pubmed_authors><pubmed_authors>Vandecruys P</pubmed_authors><pubmed_authors>Deleu S</pubmed_authors><pubmed_authors>de Carvalho BT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enhancing probiotic impact: engineering &lt;i>Saccharomyces boulardii&lt;/i> for optimal acetic acid production and gastric passage tolerance.</name><description>&lt;i>Saccharomyces boulardii&lt;/i> has been a subject of growing interest due to its potential as a probiotic microorganism with applications in gastrointestinal health, but the molecular cause for its probiotic potency has remained elusive. The recent discovery that &lt;i>S. boulardii&lt;/i> contains unique mutations causing high acetic acid accumulation and inhibition of bacterial growth provides a possible clue. The natural &lt;i>S. boulardii&lt;/i> isolates Sb.P and Sb.A are homozygous for the recessive mutation &lt;i>whi2&lt;/i>&lt;sup>S270*&lt;/sup> and accumulate unusually high amounts of acetic acid, which strongly inhibit bacterial growth. However, the homozygous &lt;i>whi2&lt;/i>&lt;sup>S270*&lt;/sup> mutation also leads to acetic acid sensitivity and acid sensitivity in general. In the present study, we have construct</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-05-07T14:19:12.247Z</modification><creation>2025-04-04T23:54:49.584Z</creation></dates><accession>S-EPMC11218656</accession><cross_references><pubmed>38752748</pubmed><doi>10.1128/aem.00325-24</doi></cross_references></HashMap>